In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

B-Acute Lymphoblastic Leukemia · B Cell Non-Hodgkin's Lymphoma · Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan, China
Contact: Study coordinator (Wang Sanbin, PhD) · sanbin1011@163.com · +86 13187424131
Sanbin

Study leads

Wang Sanbin, MD
Principal Investigator
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Hematologic Malignancy · Large B-cell Lymphoma · Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States

Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Beijing, China

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Lymphoblastic Leukemia, Acute, Childhood · Lymphoblastic Leukemia · Lymphoblastic Leukemia, Acute Adult

Abroad (travel likely)RecruitingPHASE1

Singapore, Singapore